Detalles de la búsqueda
1.
Rapid resolution of migraine symptoms after initiating the preventive treatment eptinezumab during a migraine attack: results from the randomized RELIEF trial.
BMC Neurol
; 22(1): 205, 2022 Jun 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-35659622
2.
Optimization of acute medication use following eptinezumab initiation during a migraine attack: post hoc analysis of the RELIEF study.
J Headache Pain
; 23(1): 91, 2022 Jul 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-35902796
3.
Eptinezumab treatment initiated during a migraine attack is associated with meaningful improvement in patient-reported outcome measures: secondary results from the randomized controlled RELIEF study.
J Headache Pain
; 23(1): 22, 2022 Feb 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35130832
4.
Effects of Intravenous Eptinezumab vs Placebo on Headache Pain and Most Bothersome Symptom When Initiated During a Migraine Attack: A Randomized Clinical Trial.
JAMA
; 325(23): 2348-2356, 2021 06 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-34128999
5.
Effect of Brexpiprazole on Prolactin: An Analysis of Short- and Long-Term Studies in Schizophrenia.
J Clin Psychopharmacol
; 39(1): 13-19, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-30566415
6.
A randomised, placebo-controlled 24-week study evaluating adjunctive brexpiprazole in patients with major depressive disorder.
Acta Neuropsychiatr
; 31(1): 27-35, 2019 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-30223911
7.
Correction: Rapid resolution of migraine symptoms after initiating the preventive treatment eptinezumab during a migraine attack: results from the randomized RELIEF trial.
BMC Neurol
; 23(1): 318, 2023 Sep 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-37674117
8.
Safety and Tolerability of Desmoteplase Within 3 to 9 Hours After Symptoms Onset in Japanese Patients With Ischemic Stroke.
Stroke
; 46(9): 2549-54, 2015 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-26251244
9.
Refinement of the magnetic resonance diffusion-perfusion mismatch concept for thrombolytic patient selection: insights from the desmoteplase in acute stroke trials.
Stroke
; 43(9): 2313-8, 2012 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-22738918
10.
Vascular occlusion enables selecting acute ischemic stroke patients for treatment with desmoteplase.
Stroke
; 43(6): 1561-6, 2012 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-22474060
11.
Durability of the Clinical Benefit of Droxidopa for Neurogenic Orthostatic Hypotension During 12 Weeks of Open-Label Treatment.
Neurol Ther
; 11(1): 459-469, 2022 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-35107750
12.
Chronobiologic parameter changes in patients with major depressive disorder and sleep disturbance treated with adjunctive brexpiprazole: An open-label, flexible-dose, exploratory substudy.
J Affect Disord
; 278: 288-295, 2021 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32979560
13.
Characterization of the changes in supine blood pressure with long-term use of droxidopa in patients with neurogenic orthostatic hypotension.
Health Sci Rep
; 4(1): e227, 2021 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-33521332
14.
Vortioxetine for attention deficit hyperactivity disorder in adults: A randomized, double-blind, placebo-controlled, proof-of-concept study.
J Psychopharmacol
; 33(4): 511-521, 2019 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-30843450
15.
Efficacy of vortioxetine on the physical symptoms of major depressive disorder.
J Psychopharmacol
; 32(10): 1086-1097, 2018 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-30047820
16.
Cross-centre replication of suppressed burrowing behaviour as an ethologically relevant pain outcome measure in the rat: a prospective multicentre study.
Pain
; 157(10): 2350-2365, 2016 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-27820160
17.
Cross-centre replication of suppressed burrowing behaviour as an ethologically relevant pain outcome measure in the rat: a prospective multicentre study.
Pain
; 157(10): 2350-65, 2016 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-27643836
Resultados
1 -
17
de 17
1
Próxima >
>>